FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

37359111000001102: Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 10-Jul 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
303841000001115 Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
303851000001117 Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Has AMP Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Is a Colesevelam 625mg tablets 180 tablet true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Has specific active ingredient Colesevelam hydrochloride true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Cholestagel 625mg tablets (Mawdsley-Brooks & Company Ltd) 180 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start